From Wikipedia, the free encyclopedia
 |
This article is within the scope of the Molecular and Cellular Biology WikiProject. To participate, visit the WikiProject for more information. The WikiProject's current monthly collaboration is focused on improving Restriction enzyme.
|
| Start |
This article has been rated as start-Class on the assessment scale.
|
| Low |
This article is on a subject of low-importance within molecular and cellular biology. |
|
Article Grading: The article has been rated for quality and/or importance but has no comments yet. If appropriate, please review the article and then leave comments here to identify the strengths and weaknesses of the article and what work it will need.
|
[edit] Therapeutic use
Infusion of factor XIII-A2 is clinically feasible[1]. JFW | T@lk 21:58, 21 June 2006 (UTC)
[edit] Physiology
This article explains the physiology quite nicely. JFW | T@lk 17:04, 3 July 2006 (UTC)
[edit] Standardisation
doi:10.1111/j.1538-7836.2007.02684.x JFW | T@lk 20:58, 5 July 2007 (UTC)
[edit] Prothrombotic
FXIII polymorphisms causing thrombosis in oral contraceptive use JFW | T@lk 07:57, 5 December 2007 (UTC)